Explore
Validate
Learn
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MHFH01-4 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Fetal Hemoglobin Monoclonal Antibody (HBF-1), FITC
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Commonly used, FITC conjugates provide relatively high absorptivity, excellent fluorescence quantum yield, and good water solubility. This Fetal Hemoglobin monoclonal antibody specifically recognizes fetal hemoglobin found in fetal erythrocytes.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- HBF-1
- Vial size
- 2 mL
- Storage
- 4° C, store in dark
Submitted references ZNF410 represses fetal globin by singular control of CHD4.
BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.
Hemoglobin F mitigation of sickle cell complications decreases with aging.
Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.
Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cells.
Vinjamur DS, Yao Q, Cole MA, McGuckin C, Ren C, Zeng J, Hossain M, Luk K, Wolfe SA, Pinello L, Bauer DE
Nature genetics 2021 May;53(5):719-728
Nature genetics 2021 May;53(5):719-728
BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.
Liu S, Wu M, Lancelot M, Deng J, Gao Y, Roback JD, Chen T, Cheng L
Molecular therapy : the journal of the American Society of Gene Therapy 2021 May 5;29(5):1918-1932
Molecular therapy : the journal of the American Society of Gene Therapy 2021 May 5;29(5):1918-1932
Hemoglobin F mitigation of sickle cell complications decreases with aging.
Tolu SS, Reyes-Gil M, Ogu UO, Thomas M, Bouhassira EE, Minniti CP
American journal of hematology 2020 May;95(5):E122-E125
American journal of hematology 2020 May;95(5):E122-E125
Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
Krishnamoorthy S, Pace B, Gupta D, Sturtevant S, Li B, Makala L, Brittain J, Moore N, Vieira BF, Thullen T, Stone I, Li H, Hobbs WE, Light DR
JCI insight 2017 Oct 19;2(20)
JCI insight 2017 Oct 19;2(20)
Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.
Shearstone JR, Golonzhka O, Chonkar A, Tamang D, van Duzer JH, Jones SS, Jarpe MB
PloS one 2016;11(4):e0153767
PloS one 2016;11(4):e0153767
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.
Huang X, Shah S, Wang J, Ye Z, Dowey SN, Tsang KM, Mendelsohn LG, Kato GJ, Kickler TS, Cheng L
Molecular therapy : the journal of the American Society of Gene Therapy 2014 Feb;22(2):451-463
Molecular therapy : the journal of the American Society of Gene Therapy 2014 Feb;22(2):451-463
Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cells.
Li H, Xie W, Gore ER, Montoute MN, Bee WT, Zappacosta F, Zeng X, Wu Z, Kallal L, Ames RS, Pope AJ, Benowitz A, Erickson-Miller CL
Journal of biomolecular screening 2013 Dec;18(10):1212-22
Journal of biomolecular screening 2013 Dec;18(10):1212-22
No comments: Submit comment
No validations: Submit validation data